Cargando…

Ultrastructural analysis of breast cancer patient-derived organoids

BACKGROUND: Breast cancer Patient Derived Organoids (PDO) have been demonstrated to be a reliable model to study cancer that promised to replace and reduce the use of animals in pre-clinical research. They displayed concordance with the tissue of origin, resuming its heterogenicity and representing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Signati, Lorena, Allevi, Raffaele, Piccotti, Francesca, Albasini, Sara, Villani, Laura, Sevieri, Marta, Bonizzi, Arianna, Corsi, Fabio, Mazzucchelli, Serena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353820/ https://www.ncbi.nlm.nih.gov/pubmed/34376194 http://dx.doi.org/10.1186/s12935-021-02135-z

Ejemplares similares

Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
por: Mazzucchelli, S., et al.
Publicado: (2019)

HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment
por: Sitia, Leopoldo, et al.
Publicado: (2022)

Development of Tumor-Targeted Indocyanine Green-Loaded Ferritin Nanoparticles for Intraoperative Detection of Cancers
por: Sitia, Leopoldo, et al.
Publicado: (2020)

Combined Method to Remove Endotoxins from Protein Nanocages for Drug Delivery Applications: The Case of Human Ferritin
por: Silva, Filippo, et al.
Publicado: (2021)

Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer
por: Sevieri, Marta, et al.
Publicado: (2021)

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
por: Bonizzi, Arianna, et al.
Publicado: (2019)

Indocyanine Green Nanoparticles: Are They Compelling for Cancer Treatment?
por: Sevieri, Marta, et al.
Publicado: (2020)

Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review
por: Mainini, Francesco, et al.
Publicado: (2021)

Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy
por: Truffi, Marta, et al.
Publicado: (2019)

Novel Bioengineering Strategies to Improve Bioavailability and In Vivo Circulation of H-Ferritin Nanocages by Surface Functionalization
por: Sevieri, Marta, et al.
Publicado: (2023)

Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax
por: Sitia, Leopoldo, et al.
Publicado: (2021)

In Vitro Immunoreactivity Evaluation of H-Ferritin-Based Nanodrugs
por: Sitia, Leopoldo, et al.
Publicado: (2023)

Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells
por: Truffi, Marta, et al.
Publicado: (2018)

Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease
por: Truffi, Marta, et al.
Publicado: (2020)

HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity
por: Bonizzi, Arianna, et al.
Publicado: (2021)

Lipofilling in Breast Oncological Surgery: A Safe Opportunity or Risk for Cancer Recurrence?
por: Piccotti, Francesca, et al.
Publicado: (2021)

Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease
por: Corsi, Fabio, et al.
Publicado: (2021)

Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
por: Truffi, Marta, et al.
Publicado: (2021)

Whitlockite has a characteristic distribution in mammary microcalcifications and it is not associated with breast cancer
por: Morasso, Carlo, et al.
Publicado: (2023)

Development and Validation of a Bioanalytical UHPLC-MS/MS Method Applied to Murine Liver Tissue for the Determination of Indocyanine Green Loaded in H-Ferritin Nanoparticles
por: Sottani, Cristina, et al.
Publicado: (2022)

Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era
por: Corsi, Fabio, et al.
Publicado: (2020)

Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Truffi, Marta, et al.
Publicado: (2022)

Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer’s Disease Patients
por: Gagliardi, Stella, et al.
Publicado: (2022)

Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
por: Wang, Zhiwei, et al.
Publicado: (2021)

Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model
por: Andreata, F., et al.
Publicado: (2020)

Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA)
por: Morasso, Carlo, et al.
Publicado: (2021)

Establishment and characterization of breast cancer organoids from a patient with mammary Paget’s disease
por: Pan, Bo, et al.
Publicado: (2020)

Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
por: Li, Xuelu, et al.
Publicado: (2020)

Vγ9Vδ2 T cells strengthen cisplatin inhibition activity against breast cancer MDA-MB-231 cells by disrupting mitochondrial function and cell ultrastructure
por: Huang, Xin, et al.
Publicado: (2021)

Adult separation anxiety in patients with complicated grief versus healthy control subjects: relationships with lifetime depressive and hypomanic symptoms
por: Dell'Osso, Liliana, et al.
Publicado: (2011)

Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation
por: Henes, Melanie, et al.
Publicado: (2018)

Telehealth intervention for Latina breast cancer survivors: A pilot
por: Meneses, Karen, et al.
Publicado: (2018)

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening
por: Woof, Victoria G, et al.
Publicado: (2021)

Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2020)

Health system experiences of breast cancer survivors in urban South Africa
por: Lambert, Madeleine, et al.
Publicado: (2020)

The implications of women’s activity limitations and role disruptions during breast cancer survivorship
por: Keesing, Sharon, et al.
Publicado: (2018)

The relationship between breast size and aspects of health and psychological wellbeing in mature-aged women
por: Spencer, Linda, et al.
Publicado: (2020)

“I never heard anything about it”: Knowledge and psychosocial needs of Latina breast cancer survivors with lymphedema
por: Buki, Lydia P, et al.
Publicado: (2021)

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity
por: Mazzucchelli, Serena, et al.
Publicado: (2016)

Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues
por: Shen, Chao, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_qnsknu3i5v9sbjoahs1eogbip3